Nurse-Led Testing & Screening Clinic
20 Old Brompton Road, South Kensington, London SW7 3DL
Underarm anti-sweating injections use a prescription-only medicine, botulinum toxin, to temporarily reduce signalling between local nerve endings and sweat glands. In selected patients with axillary hyperhidrosis, this can reduce excessive sweating for several months.
London GP Clinic provides nurse-led diagnostic testing and health screening. It does not provide GP consultations, diagnosis, treatment, or emergency care.
They use prescription-only botulinum toxin to temporarily block the nerve signal that stimulates sweat glands. In selected patients with axillary hyperhidrosis, this can reduce underarm sweating for several months, after which effects gradually wear off and reassessment may be needed.
Axillary hyperhidrosis means underarm sweating that is excessive relative to temperature or activity and can disrupt daily life. It can affect clothing choice, social confidence, and work comfort. Some people have primary hyperhidrosis without an underlying systemic cause, while others may have secondary sweating linked to medications or medical conditions that need separate assessment.
Sweat glands are stimulated by chemical nerve signals, including acetylcholine. Botulinum toxin can temporarily block this signal in the treated area, so sweat production is reduced until nerve activity gradually recovers. This mechanism is similar to other clinician-led injectable pathways, although treatment goals differ by indication.
This option may be considered for adults with persistent underarm sweating that has not responded sufficiently to conservative measures such as strong antiperspirants. Suitability depends on symptom severity, treatment history, medical background, and informed discussion of benefits and limitations.
Pregnancy, breastfeeding, active skin infection at the treatment site, certain neuromuscular conditions, and specific medication interactions can affect suitability. Individual screening is essential before any treatment decision.
This treatment is not suitable for everyone. Pregnancy, breastfeeding, certain neuromuscular conditions, medication interactions, or active skin infection in the treatment area may affect suitability. Individual assessment is essential and should follow a structured review framework used across injectable care, including pre-treatment suitability assessment for skin booster procedures. If symptoms become severe, rapidly worsen, or include systemic concerns, seek prompt medical advice via NHS 111 or emergency services as appropriate.
Most patients return quickly to normal routines. Practical aftercare may include keeping the area clean, avoiding vigorous activity briefly if advised, and reporting unexpected symptoms. Follow-up allows review of effect, duration, and whether further treatment should be considered. Some readers also find it useful to understand wider clinician-led injectable aftercare pathways, such as follow-up patterns used in Profhilo treatment programmes, while recognising that indications are different.
Anti-sweating injections are one option in a broader management pathway. Other approaches can include topical clinical-strength antiperspirants, oral medicines in selected cases, and specialist referral when diagnosis is uncertain. The most suitable route depends on severity, cause, and patient priorities. For patients comparing how treatment planning is structured across non-surgical injectable care, examples such as clinical review steps in Jalupro skin biorevitalisation pathways can offer general context without replacing condition-specific assessment.
Some people notice changes within several days, with fuller effect often appearing over a couple of weeks.
Duration varies, but many patients experience benefit for several months before sweating gradually returns.
No. It is generally a temporary management option rather than a permanent cure.
Often yes, depending on clinical advice. Many patients still use practical skincare and sweating-management routines.
For appropriate candidates, underarm anti-sweating injections may offer meaningful temporary improvement in sweating and quality of life. Decisions should be made after qualified clinical assessment, with realistic expectations about duration and repeat treatment.
This article is intended for general educational and informational purposes only and does not constitute personalised medical advice, diagnosis, or treatment.
Individual symptoms and test findings can have different causes and should be assessed by an appropriately qualified healthcare professional where necessary.
If symptoms are severe, rapidly worsening, or suggest a potentially serious reaction, seek urgent medical attention through appropriate NHS pathways.
Written Date: 18/09/2026
Next Review Date: 18/09/2027